Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 7, 2008

View Archived Issues

Inhibitors of JAK2 V617F mutation developed at SGX Pharmaceuticals

IMC-3G3 well tolerated in phase I advanced solid tumor study

AVX-13616 active against Gram-positive, vancomycin-resistant pathogens

Snapshots of studies of a new fluoroquinolone, finafloxacin

Pfizer discontinues phase III program for CP-945,598 for weight management

Salvat submits complete response to FDA approvable letter for Cetraxal

AEGR-733 phase II data demonstrates significant lowering of LDL cholesterol

Poniard presents top-line results from phase I oral picoplatin trial

AnaMar raises funds for chronic joint diseases clinical program

Bavarian reports successful safety data from phase II Imvamune study

FDA approves Ranexa for first-line treatment of chronic angina

Repligen initiates phase IIb RG-2417 study in bipolar disorder

Recent Dainippon Sumitomo patent discloses new antiinflammatory agents

Recent Pfizer patent imparts new therapeutic agents for glaucoma

CEM-101 snapshots: Synthesis, preclinical testing, phase I data

ConjuChem presents an update on the clinical development of PC-DAC and PC-Insulin

Canopus granted permission to initiate phase II clinical trial of CB-5300 in HCV

Sanochemia and Avigen terminate licensing agreement for tolperisone for MS

NMRC to develop dengue DNA vaccine formulated with Vical's Vaxfectin

Exelixis and Bristol-Myers extend research agreement for therapies targeted against LXR

Novel agents for liver diseases reported in recent Nisshin patent

BTG licenses novel anticancer compound BGC-945 to Onyx

Phase III study shows Tarceva improves progression-free survival in NSCLC

WuXi PharmaTech collaborates with Pfizer on ADME assays

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...